A New Beginning After Severe COVID-19: Long-Term Quality of Life Study

Year 2025, Volume: 11 Issue: 1, 49 - 55, 24.01.2025

Sinem Berik Safçi , Gülşah Yaşa Öztürk , Tarık Salcan

https://doi.org/10.53394/akd.1404770

Abstract

ABSTRACT
Objective: The pandemic caused by coronavirus (2019-nCoV) overwhelmed the health systems and became an important cause of morbidity and mortality. It reduces health-related quality of life by causing long-term physical, mental and cognitive disorders. Our aim is to evaluate the long-term effects of COVID-19 on patients by assessing quality of life and respiratory functions of the patients with severe COVID-19 during hospital follow-up and one year after discharge.
Material and Methods: This is a retrospective cross-sectional study. Data from the Nothingam Health Profile (NSP) questionnaire and the Modified Medical Research Council Scale (mMRC), which were administered to patients in person on the first day of their ICU discharge and again in person and via telemedicine at month 12, were scanned from the files. Wilcoxon Signed-Rank test was used for statistical analyses, p < .05 value was considered significant.
Results: The patients’ mean scores according to the NHP scale were 29.5±37.6 for pain, 23.4±25.5 for emotional variables, 39±36.1 for sleep, 25±33.2 for social isolation, 65±33.7 for physical activity, 98.2±9.1 for energy, and the total score for part 1 was 280.3±95.1 (p ˂ .001). Although a statistically significant decrease was detected in the mean scores of the NHP scale at the 12th month, the increase remained.
Conclusion: It is of great importance for public health that patients with COVID-19 are followed up and treated in terms of post-COVID syndrome.

Keywords

Post Covid-19 syndrome, Nottingham Health Profile Questionnaire, Public Health

Şiddetli COVID-19 Sonrası Yeni Bir Başlangıç: Uzun Dönem Hayat Kalitesi Çalışması

Abstract

ÖZ
Amaç: Koronavirüs (2019-nCoV) sebep olduğu pandemi ile önemli bir morbidite ve mortalite nedeni olarak sağlık sistemini ele geçirmiştir. Uzun dönem fiziksel, mental ve kognitif bozukluklar oluşturarak sağlık ilişkili hayat kalitesini düşürmektedir. Amacımız, ağır dereceli COVID-19 tanısı almış hastaların hastanede takipleri esnasında ve taburculuktan bir yıl sonrasındaki süreçte hayat kalitesi ve solunum fonksiyonu açısından değerlendirilmesi ile COVID-19'un uzun dönemde hastalar üzerindeki etkisini araştırmaktır.
Gereç ve Yöntemler: Bu çalışma, retrospektif kesitsel tiptedir. Hastalara yoğun bakım taburculuklarının birinci günü yüz yüze ve on ikinci ayında yüz yüze ve teletıp uygulaması ile uygulanan Nothingam Sağlık Profili (NSP) anketi ve Modifiye Medikal Araştırma Kurulu Skalası (mMRC) verileri dosyalardan tarandı. İstatiksel analizlerde Wilcoxon Signed-Rank testi kullanıldı, p < ,05 değeri anlamlı kabul edildi.
Bulgular: Hastaların ilk NSP skalasına göre ortalamaları, ağrı; 29,5±37,6, duygusal reaksiyon; 23,4±25,5, uyku; 39±36,1, sosyal izolasyon; 25±33,2, fiziksel aktivite; 65±33,7, enerji: 98,2±9,1, birinci bölüm toplam puanı; 280,3±95,1 (p ˂ .001) olarak bulunmuştur. On ikinci ay yapılan NSP skalası ortalama puanlarında istatistiksel olarak anlamlı düşüş saptanmasına rağmen yükseklik devam etmektedir.
Sonuç: COVID-19 geçiren hastaların post-COVID sendromu açısından takiplerinin yapılıp, gerekli önlemlerin alınması toplum sağlığı açısından büyük öneme sahiptir.

Keywords

Post Covid-19 sendromu, Nottingham Sağlık Profili Anketi, Halk Sağlığı

References

• 1) WHO Coronavirus (COVID-19) Dashboard | WHO Coronavirus (COVID-19) Dashboard With Vaccination Data). http//www.covid19.who.int. Access date: 23 December 2022.
• 2) Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, Wu Y, Zhang L, Yu Z, Fang M, Yu T, Wang Y, Pan S, Zou X, Yuan S, Shang Y. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020; 8(5):475-81. Epub 2020 Feb 24. Erratum in: Lancet Respir Med. 2020;8(4):e26. PMID: 32105632; PMCID: PMC7102538.
• 3) Frota AX, Vieira MC, Soares CCS, Silva PSD, Silva GMSD, Mendes FSNS, Mazzoli-Rocha F, Veloso HH, Costa ADD, Lamas CDC, Valete-Rosalino CM, Gonçalves TR, Costa HS, Rodrigues Junior LF, Mediano MFF. Functional capacity and rehabilitation strategies in Covid-19 patients: current knowledge and challenges. Rev Soc Bras Med Trop 2021; 54:e07892020.
• 4) Venkatesan P. NICE guideline on long COVID. Lancet Respir Med 2021; 9(2):129.
• 5) Heesakkers H, van der Hoeven JG, Corsten S, Janssen I, Ewalds E, Simons KS, Westerhof B, Rettig TCD, Jacobs C, van Santen S, Slooter AJC, van der Woude MCE, van den Boogaard M, Zegers M. Clinical Outcomes Among Patients With 1-Year Survival Following Intensive Care Unit Treatment for COVID-19. JAMA 2022; 327(6):559-65.
• 6) Herridge MS, Cheung AM, Tansey CM, Matte-Martyn A, Diaz-Granados N, Al-Saidi F, Cooper AB, Guest CB, Mazer CD, Mehta S, Stewart TE, Barr A, Cook D, Slutsky AS; Canadian Critical Care Trials Group. One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med 2003; 348(8):683-93.
• 7) WHOQOL - Measuring Quality of Life| The World Health Organization. http//www.eho.int. Access date: 23 December 2022.
• 8) Hunt SM, McEwen J, McKenna SP. Measuring Health Status: A New Tool For Clinicians and Epidemiologists. The Journal of the Royal College of General Practitioners 1985; 35(273):185-8.
• 9) Şimşek TT, Yümin TE, Sertel M, Öztürk A, Yümin M. Kadın ve Erkek Yaşlı Bireylerde Depresyonun Sağlıkla İlgili Yaşam Kalitesi ve Yaşam Memnuniyeti Üzerine Etkisi. Türk Geriatri Dergisi 2017; 14(4):321-30.
• 10) Fletcher C. The Clinical Diagnosisof Pulmonary Emphysema: An Experimental Study. Proceedings of the Royal Society of Medicine 1952; 45(9):577-84.
• 11) Holman W.J, Dawlish, Devon. Medical Research Coincil Committee On Research İnto Bronchitis. Instructions For Use Of The Questionnaire On Respiratory Symptoms. London, Medical Research Council, 1966.
• 12) Bestall JC, Paul EA, Garrod R. Usefulness Of The Medical Research Council (MRC) Dyspnea Scale As A Measure Of Disability İn Patients With Chronic Obstructive Pulmonary Disease. Thorax 1999; 54:581-6.
• 13) Wilson R.C, Jones P.W. A Comparision Of A Visual Analogue Scale And Modified Borg Scale For The Measurement Of Dyspnea During Exercise. Clinical Science 1989; 76(3): 277-82.
• 14) Eltayara L, Becklake MR, Volta CA, Milic-Emili J. Relationship between chronic dyspnea and expiratory flow limitation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 154(6 Pt 1):1726-34.
• 15 COVID-19 rapid guideline: managing the long-term effects of COVID-19. London: National Institute for Health and Care Excellence (NICE); 2024 Jan 25. PMID: 33555768.
• 16) Mohiuddin Chowdhury ATM, Karim MR, Ali MA, Islam J, Li Y, He S. Clinical Characteristics and the Long-Term Post-recovery Manifestations of the COVID-19 Patients-A Prospective Multicenter Cross-Sectional Study. Front Med (Lausanne) 2021; 8:663670.
• 17) Sivan M, Rayner C, Delaney B. Fresh evidence of the scale and scope of long covid. BMJ 2021; 373: n853.
• 18) Karaarslan F, Güneri FD, Kardeş S. Long COVID: rheumatologic/musculoskeletal symptoms in hospitalized COVID-19 survivors at 3 and 6 months. Clin Rheumatol 2022; 41(1):289–96.
• 19) Machelska H. Targeting of opioid-producing leukocytes for pain control. Neuropeptides 2007; 41(6):355-63.
• 20) Başhan İ, Yaşa Öztürk G. The Relationship Between COVID-19 and Secondary Chronic Musculoskeletal Pain. J Immunol Clin Microbiol 2023; 8(2):46-54.
• 21) Mohiuddin Chowdhury ATM, Karim MR, Ali MA, Islam J, Li Y, He S. Clinical Characteristics and the Long-Term Post-recovery Manifestations of the COVID-19 Patients-A Prospective Multicenter Cross-Sectional Study. Front Med (Lausanne) 2021; 8:663670.
• 22) Ceban F, Nogo D, Carvalho IP, Lee Y, Nasri F, Xiong J, Lui LMW, Subramaniapillai M, Gill H, Liu RN, Joseph P, Teopiz KM, Cao B, Mansur RB, Lin K, Rosenblat JD, Ho RC, McIntyre RS. Association Between Mood Disorders and Risk of COVID-19 Infection, Hospitalization, and Death: A Systematic Review and Meta-analysis. JAMA Psychiatry 2021; 78(10):1079-91.
• 23) Vlake JH, Wesselius S, van Genderen ME, van Bommel J, Boxma-de Klerk B, Wils EJ. Psychological distress and health-related quality of life in patients after hospitalization during the COVID-19 pandemic: A single-center, observational study. PLoS One 2021; 16(8):e0255774.
• 24) Reinke H, Asher G. Crosstalk between metabolism and circadian clocks. Nat Rev Mol Cell Biol 2019; 20(4):227–41.
• 25) Jahrami HA, Alhaj OA, Humood AM, Alenezi AF, Fekih-Romdhane F, AlRasheed MM, Saif ZQ, Bragazzi NL, Pandi-Perumal SR, BaHammam AS, Vitiello MV. Sleep disturbances during the COVID-19 pandemic: A systematic review, meta-analysis, and meta-regression. Sleep Med Rev 2022; 62:101591.
• 26) Hwang TJ, Rabheru K, Peisah C, Reichman W, Ikeda M. Loneliness and social isolation during the COVID-19 pandemic. Int Psychogeriatr 2020; 32(10):1217-20.
• 27) Murayama H, Okubo R, Tabuchi T. Increase in Social Isolation during the COVID-19 Pandemic and Its Association with Mental Health: Findings from the JACSIS 2020 Study. Int J Environ Res Public Health 2021; 18(16):8238.
• 28) Huang L, Yao Q, Gu X, Wang Q, Ren L, Wang Y, Hu P, Guo L, Liu M, Xu J, Zhang X, Qu Y, Fan Y, Li X, Li C, Yu T, Xia J, Wei M, Chen L, Li Y, Xiao F, Liu D, Wang J, Wang X, Cao B. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet 2021; 398(10302):747-58.
• 29) Tenforde MW, Kim SS, Lindsell CJ, Billig Rose E, Shapiro NI, Files DC, Gibbs KW, Erickson HL, Steingrub JS, Smithline HA, Gong MN, Aboodi MS, Exline MC, Henning DJ, Wilson JG, Khan A, Qadir N, Brown SM, Peltan ID, Rice TW, Hager DN, Ginde AA, Stubblefield WB, Patel MM, Self WH, Feldstein LR; IVY Network Investigators; CDC COVID-19 Response Team; IVY Network Investigators. Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network- United States, March-June 2020. MMWR Morb Mortal Wkly Rep 2020; 69(30):993-8.
• 30) Miller A. COVID-19: Not just an acute illness. Trends Urol Men's Health 2020; 11:17–9.
• 31) Ceban F, Ling S, Lui LMW, Lee Y, Gill H, Teopiz KM, Rodrigues NB, Subramaniapillai M, Di Vincenzo JD, Cao B, Lin K, Mansur RB, Ho RC, Rosenblat JD, Miskowiak KW, Vinberg M, Maletic V, McIntyre RS. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis. Brain Behav Immun 2022; 101:93-135.
• 32) Cares-Marambio K, Montenegro-Jiménez Y, Torres-Castro R, Vera-Uribe R, Torralba Y, Alsina-Restoy X, Vasconcello-Castillo L, Vilaró J. Prevalence of potential respiratory symptoms in survivors of hospital admission after coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. Chron Respir Dis 2021; 18:14799731211002240.
• 33) van der Sar-van der Brugge S, Talman S, Boonman-de Winter L, de Mol M, Hoefman E, van Etten RW, De Backer IC. Pulmonary function and health-related quality of life after COVID-19 pneumonia. Respir Med 2021; 176:106272.
• 34) Fernández-de-las-Peñas C, Cancela-Cilleruelo I, Rodríguez-Jiménez J, Fuensalida-Novo S, Martín-Guerrero JD, Pellicer-Valero OJ, de-la-Llave-Rincón AI. Trajectory of Post-COVID Self-Reported Fatigue and Dyspnoea in Individuals Who Had Been Hospitalized by COVID-19: The LONG-COVID-EXP Multicenter Study. Biomedicines 2023; 11(7):1863.
• 35) Jacobs LG, Gourna Paleoudis E, Lesky-Di Bari D, Nyirenda T, Friedman T, Gupta A, Rasouli L, Zetkulic M, Balani B, Ogedegbe C, Bawa H, Berrol L, Qureshi N, Aschner JL. Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection. PLoS One 2020; 15(12):e0243882.
• 36) d'Ettorre G, Vassalini P, Coppolelli V, Gentilini Cacciola E, Sanitinelli L, Maddaloni L, Fabris S, Mastroianni CM, d'Ettorre G, Ceccarelli G. Health-related quality of life in survivors of severe COVID-19 infection. Pharmacol Rep 2022; 74(6):1286-95.
• 37) Betschart M, Rezek S, Unger I, Ott N, Beyer S, Böni A, Gisi D, Shannon H, Spruit MA, Sieber C. One year follow-up of physical performance and quality of life in patients surviving COVID-19: a prospective cohort study. Swiss Med Wkly 2021; 151:w30072.
• 38) Mitrović-Ajtić O, Stanisavljević D, Miljatović S, Dragojević T, Živković E, Šabanović M, Čokić VP. Quality of Life in Post-COVID-19 Patients after Hospitalization. Healthcare (Basel)2022; 10(9):1666.